From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Dechra Pharmaceuticals reports rising pet spending...but its shares fall

By Chris Bailey | Monday 6 September 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I have written a few times, most recently HERE, about the ‘development and marketing of veterinary products’ company Dechra Pharmaceuticals (DPH). Whilst I remember being very impressed by it many years ago when it listed, I concluded back in late February that it may have said ‘thanks to the love of dogs (and Brexit fears)’ but it did not work for me. Since then the stock has pushed up even further although – as noted last week – insufficiently to join the FTSE-100. And the shares are down by more than 7% as I write, so what is going on?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 08:42:45